Protillion Biosciences

About:

Protillion Biosciences specializes in the design and development of protein-based drugs.

Top Investors: Illumina Ventures, ARCH Venture Partners

Description:

Protillion Biosciences is a biotech company commercializing disruptive technology for therapeutic antibody and drug discovery and accelerating biologic research and development productivity.

Total Funding Amount:

$18M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Burlingame, California, United States

Founded Date:

2019-01-01

Founders:

Curtis Layton, David R. Walt, William Greenleaf

Number of Employees:

11-50

Last Funding Date:

2022-12-19

IPO Status:

Private

Industries: